A novel method for determining peroxisomal fatty acid β-oxidation.

Area of Science:

• Biochemistry
• Cell Biology
• Medical Research

Background:

• X-linked adrenoleukodystrophy (X-ALD) is a devastating genetic disorder characterized by impaired very long-chain fatty acid metabolism.
• Peroxisomal fatty acid beta-oxidation is a critical metabolic pathway, and its dysfunction is implicated in X-ALD pathogenesis.
• Existing methods for assessing peroxisomal function are often complex or lack specificity.

Purpose of the Study:

• To establish a novel and convenient assay for screening chemical compounds that stimulate peroxisomal fatty acid beta-oxidation.
• To validate the assay's utility in fibroblasts from patients with X-linked adrenoleukodystrophy (X-ALD).

Main Methods:

• Utilized 12-(1-pyrene)dodecanoic acid (pyrene-C12:0), a fluorescent fatty acid analog, as a substrate for beta-oxidation.
• Incubated human skin fibroblasts with pyrene-C12:0 and measured the generation of fluorescent beta-oxidation products (pyrene-C10:0, pyrene-C8:0).
• Compared beta-oxidation activity in fibroblasts from X-ALD patients, Zellweger syndrome patients, and control subjects.

Main Results:

• Pyrene-C12:0 undergoes time-dependent beta-oxidation in peroxisomes, confirmed by its absence in Zellweger syndrome fibroblasts.
• Mitochondrial beta-oxidation was ruled out as the primary pathway for pyrene-C12:0.
• X-ALD fibroblasts exhibited approximately 40% of the peroxisomal beta-oxidation activity observed in control fibroblasts.

Conclusions:

• Pyrene-C12:0 serves as an effective substrate for measuring peroxisomal fatty acid beta-oxidation activity.
• The developed assay provides a valuable tool for screening potential therapeutic compounds for X-ALD.
• This method facilitates the discovery of agents that can enhance peroxisomal function in X-ALD.